Clinical Trial Update: Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients [Phase 3]

View source ↗

Summary

Phase 3 trial completion update evaluating pentoxifylline for slowing progression of chronic kidney disease in moderate-to-high risk patients. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Walter Reed Army Medical Center | Conditions: Kidney Failure, Chronic | Phase 3 | Status: COMPLETED